BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32620125)

  • 21. Public health initiatives from hospitalized patients with COVID-19, China.
    Zhao C; Xu Y; Zhang X; Zhong Y; Long L; Zhan W; Xu T; Zhan C; Chen Y; Zhu J; Xiao W; He M
    J Infect Public Health; 2020 Sep; 13(9):1229-1236. PubMed ID: 32591163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.
    Xiong S; Liu L; Lin F; Shi J; Han L; Liu H; He L; Jiang Q; Wang Z; Fu W; Li Z; Lu Q; Chen Z; Ding S
    BMC Infect Dis; 2020 Oct; 20(1):787. PubMed ID: 33092539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
    Yang M; Chen X; Xu Y
    Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19: Abnormal liver function tests.
    Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
    J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and laboratory indicator analysis of 67 COVID-19 pneumonia patients in Suzhou, China.
    Wang Y; Yao L; Zhang JP; Tang PJ; Ye ZJ; Shen XH; Xu JC; Wu MY; Yu X
    BMC Infect Dis; 2020 Oct; 20(1):747. PubMed ID: 33046047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.
    Hou W; Zhang W; Jin R; Liang L; Xu B; Hu Z
    Infect Dis (Lond); 2020 Jul; 52(7):498-505. PubMed ID: 32370577
    [No Abstract]   [Full Text] [Related]  

  • 27. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.
    Xu X; Yu C; Qu J; Zhang L; Jiang S; Huang D; Chen B; Zhang Z; Guan W; Ling Z; Jiang R; Hu T; Ding Y; Lin L; Gan Q; Luo L; Tang X; Liu J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1275-1280. PubMed ID: 32107577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
    Huang Q; Deng X; Li Y; Sun X; Chen Q; Xie M; Liu S; Qu H; Liu S; Wang L; He G; Gong Z
    Int J Clin Pharm; 2020 Jun; 42(3):837-845. PubMed ID: 32410206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between obesity and clinical prognosis in patients infected with SARS-CoV-2.
    Cai SH; Liao W; Chen SW; Liu LL; Liu SY; Zheng ZD
    Infect Dis Poverty; 2020 Jun; 9(1):80. PubMed ID: 32600411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
    Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
    Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristics of asymptomatic COVID-19 infection and progression: A multicenter, retrospective study.
    Yu C; Zhou M; Liu Y; Guo T; Ou C; Yang L; Li Y; Li D; Hu X; Shuai L; Wang B; Zou Z
    Virulence; 2020 Dec; 11(1):1006-1014. PubMed ID: 32722990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased circulating level of interleukin-6 and CD8
    Yang PH; Ding YB; Xu Z; Pu R; Li P; Yan J; Liu JL; Meng FP; Huang L; Shi L; Jiang TJ; Qin EQ; Zhao M; Zhang DW; Zhao P; Yu LX; Wang ZH; Hong ZX; Xiao ZH; Xi Q; Zhao DX; Yu P; Zhu CZ; Chen Z; Zhang SG; Ji JS; Wang FS; Cao GW
    Infect Dis Poverty; 2020 Nov; 9(1):161. PubMed ID: 33239109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics.
    Feng Z; Yu Q; Yao S; Luo L; Zhou W; Mao X; Li J; Duan J; Yan Z; Yang M; Tan H; Ma M; Li T; Yi D; Mi Z; Zhao H; Jiang Y; He Z; Li H; Nie W; Liu Y; Zhao J; Luo M; Liu X; Rong P; Wang W
    Nat Commun; 2020 Oct; 11(1):4968. PubMed ID: 33009413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.
    Kong W; Wang Y; Hu J; Chughtai A; Pu H;
    Travel Med Infect Dis; 2020; 37():101754. PubMed ID: 32492485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China.
    Ma Y; Xu QN; Wang FL; Ma XM; Wang XY; Zhang XG; Zhang ZF
    Microbes Infect; 2020; 22(4-5):212-217. PubMed ID: 32387682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximum chest CT score is associated with progression to severe illness in patients with COVID-19: a retrospective study from Wuhan, China.
    Xiao J; Li X; Xie Y; Huang Z; Ding Y; Zhao S; Yang P; Du D; Liu B; Wang X
    BMC Infect Dis; 2020 Dec; 20(1):953. PubMed ID: 33308183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study).
    Bartoletti M; Giannella M; Scudeller L; Tedeschi S; Rinaldi M; Bussini L; Fornaro G; Pascale R; Pancaldi L; Pasquini Z; Trapani F; Badia L; Campoli C; Tadolini M; Attard L; Puoti M; Merli M; Mussini C; Menozzi M; Meschiari M; Codeluppi M; Barchiesi F; Cristini F; Saracino A; Licci A; Rapuano S; Tonetti T; Gaibani P; Ranieri VM; Viale P;
    Clin Microbiol Infect; 2020 Nov; 26(11):1545-1553. PubMed ID: 32781244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: an Observational Cohort Study.
    Korkmaz MF; Türe E; Dorum BA; Kılıç ZB
    J Korean Med Sci; 2020 Jun; 35(25):e236. PubMed ID: 32597047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.
    Ji D; Zhang D; Xu J; Chen Z; Yang T; Zhao P; Chen G; Cheng G; Wang Y; Bi J; Tan L; Lau G; Qin E
    Clin Infect Dis; 2020 Sep; 71(6):1393-1399. PubMed ID: 32271369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.
    Yang AP; Liu JP; Tao WQ; Li HM
    Int Immunopharmacol; 2020 Jul; 84():106504. PubMed ID: 32304994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.